This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2021 Jan 14;384(2):154-164.

doi: 10.1056/NEJMra2028910.

Ewing's Sarcoma

Nicolò Riggi¹, Mario L Suvà¹, Ivan Stamenkovic¹

Affiliations

Affiliation

¹ From the Institute of Pathology, Faculty of Biology and Medicine, University of Lausanne and Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (N.R., I.S.); and the Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, and the Broad Institute of Harvard University and the Massachusetts Institute of Technology, Cambridge - both in Massachusetts (M.L.S.).

PMID: 33497548
DOI: 10.1056/NEJMra2028910

Review

Ewing's Sarcoma

Nicolò Riggi et al. N Engl J Med. 2021.

. 2021 Jan 14;384(2):154-164.

doi: 10.1056/NEJMra2028910.

Authors

Nicolò Riggi¹, Mario L Suvà¹, Ivan Stamenkovic¹

Affiliation

¹ From the Institute of Pathology, Faculty of Biology and Medicine, University of Lausanne and Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (N.R., I.S.); and the Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, and the Broad Institute of Harvard University and the Massachusetts Institute of Technology, Cambridge - both in Massachusetts (M.L.S.).

PMID: 33497548
DOI: 10.1056/NEJMra2028910

No abstract available

PubMed Disclaimer

Comment in

Ewing's Sarcoma.
Ludwig JA, Meyers PA, Dirksen U. Ludwig JA, et al. N Engl J Med. 2021 Apr 15;384(15):1476. doi: 10.1056/NEJMc2102423. N Engl J Med. 2021. PMID: 33852792 No abstract available.
Ewing's Sarcoma.
Blay JY, De Pinieux G, Gouin F. Blay JY, et al. N Engl J Med. 2021 Apr 15;384(15):1477. doi: 10.1056/NEJMc2102423. N Engl J Med. 2021. PMID: 33852793 No abstract available.

Similar articles

Promiscuous partnerships in Ewing's sarcoma.
Sankar S, Lessnick SL. Sankar S, et al. Cancer Genet. 2011 Jul;204(7):351-65. doi: 10.1016/j.cancergen.2011.07.008. Cancer Genet. 2011. PMID: 21872822 Free PMC article. Review.
Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C, Ren T, Yang K, Wang S, Bao X, Zhang F, Guo W. Ren C, et al. J Exp Clin Cancer Res. 2016 Mar 11;35:44. doi: 10.1186/s13046-016-0321-3. J Exp Clin Cancer Res. 2016. PMID: 26969300 Free PMC article.
Ewing's sarcoma: a miracle drug waiting to happen?
Longtin R. Longtin R. J Natl Cancer Inst. 2003 Nov 5;95(21):1574-6. doi: 10.1093/jnci/95.21.1574. J Natl Cancer Inst. 2003. PMID: 14600088 No abstract available.
R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.
Huang HJ, Angelo LS, Rodon J, Sun M, Kuenkele KP, Parsons HA, Trent JC, Kurzrock R. Huang HJ, et al. PLoS One. 2011;6(10):e26060. doi: 10.1371/journal.pone.0026060. Epub 2011 Oct 11. PLoS One. 2011. PMID: 22022506 Free PMC article.
Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
Uren A, Toretsky JA. Uren A, et al. Future Oncol. 2005 Aug;1(4):521-8. doi: 10.2217/14796694.1.4.521. Future Oncol. 2005. PMID: 16556028 Review.

See all similar articles

Cited by

RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma.
Randolph ME, Afifi M, Gorthi A, Weil R, Wilky BA, Weinreb J, Ciero P, Hoeve NT, van Diest PJ, Raman V, Bishop AJR, Loeb DM. Randolph ME, et al. iScience. 2024 Jan 16;27(2):108925. doi: 10.1016/j.isci.2024.108925. eCollection 2024 Feb 16. iScience. 2024. PMID: 38323009 Free PMC article.
Bone marrow mesenchymal stem cell-derived exosomal LINC00847 inhibits the proliferation, migration, and invasion of Ewing sarcoma.
Huang L, Xiong J, Fu J, Zhou Z, Yu H, Xu J, Wu L, Cao K. Huang L, et al. J Clin Transl Res. 2022 Nov 24;8(6):563-576. eCollection 2022 Dec 29. J Clin Transl Res. 2022. PMID: 36518202 Free PMC article.
Identification of a novel translocation producing an in-frame fusion of TAF15 and ETV4 in a case of extraosseous Ewing sarcoma revealed in the prenatal period.
Picard C, Macagno N, Corradini N, Marec-Bérard P, Cabet S, Guibaud L, Viremouneix L, Raux S, Chotel F, Weinbreck N, Meurgey A, Karanian M, Pissaloux D, Tirode F, Dijoud F. Picard C, et al. Virchows Arch. 2022 Oct;481(4):665-669. doi: 10.1007/s00428-022-03335-2. Epub 2022 May 9. Virchows Arch. 2022. PMID: 35527322
Ewing sarcoma and related FET family translocation-associated round cell tumors: A century of clinical and scientific progress.
Maki RG, Grohar PJ, Antonescu CR. Maki RG, et al. Genes Chromosomes Cancer. 2022 Aug;61(8):509-517. doi: 10.1002/gcc.23050. Epub 2022 Apr 30. Genes Chromosomes Cancer. 2022. PMID: 35443099 Free PMC article.
Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing's Sarcoma Using Bioinformatics Analysis.
Zhang J, Huang J, Liu W, Ding L, Cheng D, Xiao H. Zhang J, et al. J Immunol Res. 2022 May 5;2022:3655908. doi: 10.1155/2022/3655908. eCollection 2022. J Immunol Res. 2022. PMID: 35578666 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information